Stock Analysis on Net
Stock Analysis on Net

AbbVie Inc. (NYSE:ABBV)

Common-Size Income Statement

AbbVie Inc., common-size consolidated income statement

Microsoft Excel
12 months ended: Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Net revenues 100.00 100.00 100.00 100.00 100.00
Cost of products sold -37.58 -30.00 -31.04 -33.59 -22.36
Gross margin 62.42% 70.00% 68.96% 66.41% 77.64%
Selling, general and administrative -23.70 -26.29 -21.97 -24.67 -20.87
Research and development -14.13 -11.21 -12.61 -14.32 -19.26
Acquired IPR&D and milestones -1.43 -1.20 -1.71 -2.62 -1.16
Other operating income (expense), net 0.33 -0.10 -0.77 0.00 2.68
Operating earnings 23.49% 31.21% 31.89% 24.81% 39.03%
Interest expense -4.09 -3.84 -4.31 -5.36 -5.36
Interest income 0.99 0.32 0.07 0.38 0.83
Interest expense, net -3.10% -3.52% -4.24% -4.98% -4.54%
Net foreign exchange loss -0.27 -0.25 -0.09 -0.16 -0.13
Other expense, net -8.61 -4.22 -4.45 -12.26 -9.04
Earnings before income tax expense 11.51% 23.21% 23.11% 7.42% 25.33%
Income tax (expense) benefit -2.54 -2.81 -2.56 2.67 -1.64
Net earnings 8.97% 20.40% 20.55% 10.09% 23.69%
Net earnings attributable to noncontrolling interest -0.02 -0.02 -0.01 -0.01 0.00
Net earnings attributable to AbbVie Inc. 8.95% 20.39% 20.54% 10.08% 23.69%

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

Income statement item Description The company
Operating earnings The net result for the period of deducting operating expenses from operating revenues. AbbVie Inc. operating earnings as a percentage of net revenues decreased from 2021 to 2022 and from 2022 to 2023.
Earnings before income tax expense Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. AbbVie Inc. earnings before income tax expense as a percentage of net revenues increased from 2021 to 2022 but then decreased significantly from 2022 to 2023.
Net earnings attributable to AbbVie Inc. The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. AbbVie Inc. net earnings attributable to AbbVie Inc. as a percentage of net revenues decreased from 2021 to 2022 and from 2022 to 2023.